The embodiments disclosed herein relate to bone implants, and more particularly to devices and methods for bone alignment, stabilization and distraction.
Bones form the skeleton of the body and allow the body to be supported against gravity and to move and function in the world. Bone fractures can occur, for example, from an outside force or from a controlled surgical cut (an osteotomy). A fracture's alignment is described as to whether the fracture fragments are displaced or in their normal anatomic position. In some instances, surgery may be required to re-align, stabilize and distract the fractured bone.
Devices and methods for bone alignment, stabilization and distraction are disclosed herein.
According to aspects illustrated herein, there is provided a bone implant that includes an expandable body having a closed end, a sealable open end, an inner cavity, an external surface and an internal surface, wherein the expandable body has an insertion depth with a fixed dimension, a width with a fixed dimension, and a thickness with a changeable dimension, and wherein entry of a fluid into the inner cavity of the expandable body changes the dimension of the device thickness. In an embodiment, the bone implant of the present disclosure is sufficiently designed to re-align fragments of a fractured bone. In an embodiment, the bone implant of the present disclosure is sufficiently designed to stabilize fragments of a fractured bone. In an embodiment, the bone implant of the present disclosure is sufficiently designed to distract fragments of a fractured bone. In an embodiment, the bone implant of the present disclosure is sufficiently designed to repair angular displacement of a fractured bone. In an embodiment, a bone implant of the present disclosure can be used to restore radial length, volar angulation, and radial inclination for a distal radius fracture with dorsal angulation.
According to aspects illustrated herein, there is provided a bone implant system that includes a light-sensitive liquid; a light source for providing light energy; a light-conducting fiber for delivering the light energy from the light source to cure the light-sensitive liquid; a delivery catheter having a proximal end in communication with the light-conducting fiber and the light-sensitive liquid, an inner lumen for passage of the light-conducting fiber, and an inner void for passage of the light-sensitive liquid; and an expandable body removably engaging a distal end of the delivery catheter, wherein the expandable body has a closed end, a sealable open end, an inner cavity for passage of the light-sensitive liquid, an external surface and an internal surface, wherein the expandable body has an insertion depth with a fixed dimension, a width with a fixed dimension, and a thickness with a changeable dimension, and wherein entry of the light-sensitive liquid into the inner cavity of the expandable body changes the dimension of the device thickness.
According to aspects illustrated herein, there is provided a method of maintaining distraction of a fractured distal radius bone that includes providing temporary distraction to a fractured distal radius bone to provide a distraction gap; delivering an expandable body in an unexpanded state into the distraction gap; infusing a first fluid into the expandable body to expand the expandable body so that a desired amount of distraction is achieved at the distraction gap; removing the first fluid from the expandable body; determining an amount of first fluid removed from the expandable body; infusing an amount of light-sensitive liquid into the expandable body to expand the expandable body, wherein the amount of light-sensitive liquid is substantially equivalent to the amount of first fluid; curing the light-sensitive liquid in the expandable body to form a rigid photodynamic device; and maintaining a desired amount of distraction at the distraction gap.
The presently disclosed embodiments will be further explained with reference to the attached drawings, wherein like structures are referred to by like numerals throughout the several views. The drawings shown are not necessarily to scale, with emphasis instead generally being placed upon illustrating the principles of the presently disclosed embodiments.
While the above-identified drawings set forth presently disclosed embodiments, other embodiments are also contemplated, as noted in the discussion. This disclosure presents illustrative embodiments by way of representation and not limitation. Numerous other modifications and embodiments can be devised by those skilled in the art which fall within the scope and spirit of the principles of the presently disclosed embodiments.
Devices and methods for bone alignment, stabilization and distraction are disclosed herein. In an embodiment, the present disclosure is directed to devices and methods for human treatment of bone fractures. In an embodiment, the present disclosure is directed to devices and methods for veterinary treatment of bone fractures.
As used herein, the term “animal” means any organism belonging to the kingdom Animalia. In an embodiment, the term “animal” refers to vertebrates, more preferably, mammals including humans. In an embodiment, an expandable body of the present disclosure is implanted in a human. In an embodiment, an expandable body of the present disclosure is implanted in an animal.
As used herein, the terms “fracture” or “fractured bone” refer to a break in the continuity of a bone. The fracture can occur, for example, from an outside force or from a controlled surgical cut (osteotomy). Considerations in fracture care are the fracture's alignment (whether the fracture fragments are displaced or in their normal anatomic position) and angulation. If angulation or displacement is large, reduction (manipulation) of the bone may be required, as well as contact-compression at the fracture surfaces.
As used herein, the term “radius” refers to the bone of the forearm that extends from the lateral side of the elbow to the thumb side of the wrist.
As used herein, the terms “distal radius fracture” and “Colles fracture” refer to a wrist fracture involving a break of the end of the radius.
As used herein, the term “photodynamic device” refers to an expandable body of the present disclosure that is infused with a photodynamic (light curable) material and exposed to an appropriate frequency of light and intensity to cure the material inside the expandable body and form a rigid structure. In an embodiment, the photodynamic device re-aligns a fractured bone. In an embodiment, the photodynamic device stabilizes a fractured bone. In an embodiment, the photodynamic device provides contact-compression at fracture surfaces. In an embodiment, the photodynamic device may be referred to as a “wedge implant” or “bone implant”.
As used herein, the term “distraction” refers to positioning a fractured bone back to a substantially normal, anatomically correct, position (separation of the bone fragments). In an embodiment, a photodynamic device of the present disclosure provides distraction to a fractured bone. In an embodiment, a photodynamic device of the present disclosure is used to distract a fractured bone which realigns the fragments to a substantially original position. In an embodiment, a photodynamic device of the present disclosure is used to distract a fractured bone and maintain an angle of the bone which realigns the fragments to a substantially original position. In an embodiment, a photodynamic device of the present disclosure is used to distract a fractured distal radius bone so that a radial tilt of the fractured distal radius is returned to a normal range between about 19° to about 25°. In an embodiment, a photodynamic device of the present disclosure is used to distract a fractured distal radius bone so that a radial length of the fractured distal radius is returned to a normal range between about 9.7 mm to about 17.3 mm. In an embodiment, a photodynamic device of the present disclosure is used to distract a fractured distal radius bone so that a radial length of the fractured distal radius is returned to a normal range of about 12 mm. In an embodiment, a photodynamic device of the present disclosure is used to distract a fractured distal radius bone so that a palmar tilt of the fractured distal radius is returned to a normal range of about 11°. In an embodiment, a photodynamic device of the present disclosure is used to distract a fractured distal radius bone so that a radial tilt of the fractured distal radius is returned to a normal range between about 19° to about 25°, a radial length of the fractured distal radius is returned to a normal range between about 9.7 mm to about 17.3 mm, a radial length of the fractured distal radius is returned to a normal range of about 12 mm, and a palmar tilt of the fractured distal radius is returned to a normal range of about 11°.
As used herein, the term “pullout strength” refers to the force required to pull a photodynamic device of the present disclosure from a fracture site.
In the embodiment shown in
As illustrated in
In an embodiment, a photodynamic device of the present disclosure can provide internal bone alignment, stabilization, and/or distraction to fractures, including, but not limited to, fractures of the hand and wrist (including, but not limited to the metacarpal bones), the forearm (including, but not limited to, the radius and ulna), the face or jaw, the foot and ankle (including, but not limited to, the metatarsal bones, the cuneiform bones, and the calcaneus bone), the pelvic area, the leg (including, but not limited to, the tibia), and other areas of the skeletal system that require angular correction. In an embodiment, a photodynamic device of the present disclosure is sufficiently designed to re-align fragments of a fractured bone. In an embodiment, a photodynamic device of the present disclosure is sufficiently designed to stabilize fragments of a fractured bone. In an embodiment, a photodynamic device of the present disclosure is sufficiently designed to distract fragments of a fractured bone. In an embodiment, a photodynamic device of the present disclosure is sufficiently designed to repair angular displacement of a fractured bone. In an embodiment, a photodynamic device of the present disclosure can provide internal bone alignment, stabilization and/or distraction of a distal radius fracture. In an embodiment, a photodynamic device of the present disclosure can provide internal bone alignment, stabilization and/or distraction of a metatarsal fracture. In an embodiment, a photodynamic device of the present disclosure can provide internal bone alignment, stabilization and/or distraction of a distal osteotomy of the first metatarsal to treat hallux valgus (bunion). In an embodiment, a photodynamic device of the present disclosure is used to align, stabilize and/or distract a wedge osteotomy of the foot. In an embodiment, a photodynamic device of the present disclosure is used during an Evans calcaneal osteotomy procedure for lateral column lengthening. In an embodiment, a photodynamic device of the present disclosure is used during a plantarflexion opening wedge medial cuneiform (Cotton) osteotomy procedure. In an embodiment, a photodynamic device of the present disclosure is used during a wedge osteotomy and stabilization of the wrist in a distal radius procedure. In an embodiment, a photodynamic device of the present disclosure is used in an open wedge osteotomy.
A common fracture, especially in the older population, is a fracture of the distal radius. This type of fracture usually results from a fall upon an outstretched hand. A fracture of the distal radius often results in parts of the wrist folding on each other which results in severe angulation of the wrist. Due to the shape of the distal radius after a fracture, as well as the lack of space and the number of tendons and nerves in the fractured area, treatment of a distal radius fracture is often complicated.
Distal radius fractures typically occur at the cortico-cancellous junction at the distal end of the radius. Fractures of the distal radius are most commonly caused by people falling forward onto a hard surface and breaking their fall with extended outstretched hands. Since 80% of the load through the wrist joint is carried by the radius it is not surprising that the fracture occurs at this junction. These fractures are the most commonly occurring fractures in adults and one out of six fractures seen in the emergency room is of this type. An anatomic description of the distal radius fracture is the easiest way to describe the fracture, decide on treatment, and make an assessment of stability. These descriptions may include an assessment of articular incongruity, radial shortening, radial angulation, comminution of the fracture (the amount of crumbling at the fracture site), and open (compound) or closed injury. The assessment may also involve other associated ulnar styloid fractures or soft tissue injuries. A distal radius fracture is often difficult to treat. This is, in part, due to the shape of the distal radius after an injury, the lack of space within the distal radius and the number of tendons and nerves in the area. When surgical treatment of a fracture is performed, it is usually done by open reduction and internal fixation with plate, rods and/or screws. If the fracture is unstable the deformity at the fracture site will increase and cause limitation of wrist motion and forearm rotation, pronation and supination. If the joint surface is damaged and heals with more than 1 mm to 2 mm of unevenness, the wrist joint will be prone to post-traumatic osteoarthritis. In an embodiment, a photodynamic device of the present disclosure is sufficiently designed to re-align fragments of a fractured distal radius bone. In an embodiment, a photodynamic device of the present disclosure is sufficiently designed to stabilize fragments of a fractured bone distal radius bone. In an embodiment, a photodynamic device of the present disclosure is sufficiently designed to distract fragments of a fractured distal radius bone. In an embodiment, a photodynamic device of the present disclosure is sufficiently designed to repair angular displacement of a fractured distal radius bone. In an embodiment, a photodynamic device of the present disclosure can be used to restore radial length, volar angulation, and radial inclination for a distal radius fracture with angulation.
In an embodiment, the expandable body 170 is thicker at a proximal area 176 (the area engaging the delivery catheter 150) and tapers in thickness as it approaches a distal area 178. A distal area 178 that tapers may allow for easier insertion of the expandable body 170. In an embodiment, the expandable body 170 has a proximal area 176 and a distal area 178 that is generally constant in thickness. In an embodiment, the thickness of the expandable body 170 may decrease along the depth of the expandable body 170 traveling from the proximal area 176 to the distal area 178. The selection of the appropriate shape and size of the expandable body 170 may be based on the type, size and location of the injury as well as the treatment goals.
The dimensions of the proximal area 176, including the depth, width, diameter or thickness, may vary based on the shape of the proximal area 176. In an embodiment, the depth of the proximal area 176 may range from about 10 mm to about 25 mm. In an embodiment, the width of the proximal area 176 may range from about 8 mm to about 25 mm. In an embodiment, the thickness of the proximal area 176 may range from about 2 mm to about 25 mm. It should be appreciated that these dimensions are only provided as examples. The dimensions of the proximal area 176 can be smaller or larger as the present disclosure is not intended to be limited in this manner.
The dimensions of the distal area 178, including the depth, width, diameter or thickness, may vary based on the shape of the distal area 178. In an embodiment, the depth of the distal area 178 may range from about 10 mm to about 25 mm. In an embodiment, the width of the distal area 178 may range from about 8 mm to about 25 mm. In an embodiment, the thickness of the distal area 178 may range from about 2 mm to about 25 mm. It should be appreciated that these dimensions are only provided as examples. The dimensions of the distal area 178 can be smaller or larger as the present disclosure is not intended to be limited in this manner.
An expandable body 170 of the present disclosure can be infused with light-sensitive liquid 165 such that the final cured photodynamic device provides distraction of about 1 mm to bone fragments. An expandable body 170 of the present disclosure can be infused with light-sensitive liquid 165 such that the final cured photodynamic device provides distraction of about 2 mm to bone fragments. An expandable body 170 of the present disclosure can be infused with light-sensitive liquid 165 such that the final cured photodynamic device provides distraction of about 3 mm to bone fragments. An expandable body 170 of the present disclosure can be infused with light-sensitive liquid 165 such that the final cured photodynamic device provides distraction of about 4 mm to bone fragments. An expandable body 170 of the present disclosure can be infused with light-sensitive liquid 165 such that the final cured photodynamic device provides distraction of about 5 mm to bone fragments. An expandable body 170 of the present disclosure can be infused with light-sensitive liquid 165 such that the final cured photodynamic device provides distraction of about 6 mm to bone fragments. An expandable body 170 of the present disclosure can be infused with light-sensitive liquid 165 such that the final cured photodynamic device provides distraction of about 7 mm to bone fragments. An expandable body 170 of the present disclosure can be infused with light-sensitive liquid 165 such that the final cured photodynamic device provides distraction of about 8 mm to bone fragments. An expandable body 170 of the present disclosure can be infused with light-sensitive liquid 165 such that the final cured photodynamic device provides distraction of about 9 mm to bone fragments. An expandable body 170 of the present disclosure can be infused with light-sensitive liquid 165 such that the final cured photodynamic device provides distraction of about 10 mm to bone fragments. An expandable body 170 of the present disclosure can be infused with light-sensitive liquid 165 such that the final cured photodynamic device provides distraction of about 11 mm to bone fragments. An expandable body 170 of the present disclosure can be infused with light-sensitive liquid 165 such that the final cured photodynamic device provides distraction of about 12 mm to bone fragments. Therefore, the expandable body 170 of the present disclosure is capable of providing customized distraction—angulation correction specific to a patient.
In an embodiment, the external surface 174 of the expandable body 170 is resilient and puncture resistant. In an embodiment, the expandable body 170 is manufactured from a non-compliant (non-stretch/non-expansion) conformable material including but not limited to urethane, polyethylene terephthalate (PET), nylon elastomer and other similar polymers. In an embodiment, the expandable body 170 is manufactured from a polyethylene terephthalate (PET). In an embodiment, the expandable body 170 is manufactured from a radiolucent material, which permit x-rays to pass through the expandable body 170. In an embodiment, the expandable body 170 is manufactured from a radiolucent polyethylene terephthalate (PET). In an embodiment, the expandable body 170 is manufactured from a conformable compliant material that is limited in dimensional change by embedded fibers. In an embodiment, at least a portion of the external surface 174 of the expandable body 170 is substantially even and smooth. In an embodiment, at least a portion of the external surface 174 of the expandable body 170 includes at least one textured element 177 such as a bump, a ridge, a rib, an indentation or any other shape. In an embodiment, at least a portion of the external surface 174 of the expandable body 170 protrudes out to form a textured element 177. In an embodiment, at least a portion of the external surface 174 of the expandable body 170 invaginates to form a textured element 177. In an embodiment, the textured element 177 increases the friction and improves the grip and stability of the expandable body 170 after the expandable body 170 is inserted into the fracture location. In an embodiment, the textured element 177 results in increased interdigitation of bone-device interface as compared to an expandable body without textured elements. In an embodiment, the textured element 177 can be convex in shape. In an embodiment, the textured element 177 can be concave in shape. In an embodiment, the textured element 177 can be circumferential around the width of the expandable body 170, either completely or partially.
In general, bone graft or bone graft substitute can be used in conjunction with an expandable body 170 of the present disclosure. In an embodiment, the bone graft is an allogeneic bone graft. In an embodiment, the bone graft is an autologous bone graft. In an embodiment, the bone graft substitute is a hydroxyapatite bone substitute. In an embodiment, a bone graft or bone graft substitute is used to fill in any gaps that may exist, for example, between the external surface 174 of the expandable body 180 and the surfaces of the bone fragments. In an embodiment, a bone graft or bone graft substitute is used to fill any gaps that may exist, for example, between the textured element 177 of the expandable body 180 and the surfaces of the bone fragments.
In general, the expandable body 170 can include an external surface that may be coated with materials including, but not limited to, drugs (for example, antibiotics), proteins (for example, growth factors) or other natural or synthetic additives (for example, radiopaque or ultrasonically active materials). For example, after a minimally invasive surgical procedure an infection may develop in a patient, requiring the patient to undergo antibiotic treatment. An antibiotic drug may be added to the external surface of the expandable body 170 to prevent or combat a possible infection. Proteins, such as, for example, bone morphogenic protein or other growth factors have been shown to induce the formation of cartilage and bone. A growth factor may be added to the external surface of the expandable body 170 to help induce the formation of new bone. Due to the lack of thermal egress of the light-sensitive liquid 165 in the expandable body 170, the effectiveness and stability of the coating is maintained.
In general, the expandable body 170 typically does not have any valves. One benefit of having no valves is that the expandable body 170 may be expanded or reduced in size as many times as necessary to assist in the fracture reduction and placement. Another benefit of the expandable body 170 having no valves is the efficacy and safety of the system 100. Since there is no communication passage of light-sensitive liquid 165 to the body there cannot be any leakage of liquid 165 because all the liquid 165 is contained within the expandable body 170. In an embodiment, a permanent seal is created between the expandable body 170 and the delivery catheter 150 that is both hardened and affixed prior to the delivery catheter 150 being removed.
In an embodiment, abrasively treating the external surface 174 of the expandable body 170 for example, by chemical etching or air propelled abrasive media, improves the connection and adhesion between the external surface 174 of the expandable body 170 and a bone surface. The surfacing significantly increases the amount of surface area that comes in contact with the bone which can result in a stronger grip.
Various embodiments of expandable body's of the present disclosure will now be discussed. In general, an expandable body of the present disclosure can include any of the features described above, with modification to some or all of the features.
In an embodiment, the external surface 274, 374 and 474 of the expandable body 270, 370 and 470 is resilient and puncture resistant. In an embodiment, the expandable body 270, 370 and 470 is manufactured from a non-compliant (non-stretch/non-expansion) conformable material including but not limited to urethane, polyethylene terephthalate (PET), nylon elastomer and other similar polymers. In an embodiment, the expandable body 270, 370 and 470 is manufactured from a polyethylene terephthalate In the embodiments illustrated in
In an embodiment, the external surface 574 of the expandable body 570 is resilient and puncture resistant. In an embodiment, the expandable body 570 is manufactured from a non-compliant (non-stretch/non-expansion) conformable material including but not limited to urethane, polyethylene terephthalate (PET), nylon elastomer and other similar polymers. In an embodiment, the expandable body 570 is manufactured from a polyethylene terephthalate (PET).
As illustrated in
In an embodiment, the external surface 674 of the expandable body 670 is resilient and puncture resistant. In an embodiment, the expandable body 670 is manufactured from a non-compliant (non-stretch/non-expansion) conformable material including but not limited to urethane, polyethylene terephthalate (PET), nylon elastomer and other similar polymers. In an embodiment, the expandable body 670 is manufactured from a polyethylene terephthalate (PET).
As illustrated in
In an embodiment, the external surface 774 of the expandable body 770 is resilient and puncture resistant. In an embodiment, the expandable body 770 is manufactured from a non-compliant (non-stretch/non-expansion) conformable material including but not limited to urethane, polyethylene terephthalate (PET), nylon elastomer and other similar polymers. In an embodiment, the expandable body 770 is manufactured from a polyethylene terephthalate (PET).
As illustrated in
In an embodiment, the external surface 874 of the expandable body 870 is resilient and puncture resistant. In an embodiment, the expandable body 870 is manufactured from a non-compliant (non-stretch/non-expansion) conformable material including but not limited to urethane, polyethylene terephthalate (PET), nylon elastomer and other similar polymers. In an embodiment, the expandable body 870 is manufactured from a polyethylene terephthalate (PET).
As illustrated in
In an embodiment, the external surface 974 of the expandable body 970 is resilient and puncture resistant. In an embodiment, the expandable body 970 is manufactured from a non-compliant (non-stretch/non-expansion) conformable material including but not limited to urethane, polyethylene terephthalate (PET), nylon elastomer and other similar polymers. In an embodiment, the expandable body 970 is manufactured from a polyethylene terephthalate (PET).
As illustrated in
In an embodiment, traction may be applied to the injured limb before surgery. Alternatively, conventional bone distraction instrumentation can be utilized or the use of K wires delivered to the lateral aspect of the bone (proximal and distal to the fracture) to assist in the initial manipulation and distraction/reduction of the bones. As illustrated in
Use of ancillary fixation is optional for improving stability. As illustrated in
In an embodiment, a photodynamic device of the present disclosure can be used in the angular correction of bones in the hand and wrist, the forearm, and the foot and ankle of an animal. In an embodiment, the initial angular correction can be reduced in conventional fashion through the use of external mechanical manipulation, traction or through the use of standard surgical instruments designed to assist in bone distraction. Once the required amount of distraction and angulation has been satisfactorily achieved via conventional means, an implant size is determined by placing an empty, unfilled expandable body of the present disclosure within the created space, and filling the expandable body with air to create a stable interface between the surfaces of the bone and the expandable body. Fluroscopy may be utilized to assist in the determination of the correct amount of distraction, and to assess the positioning of the expandable body. The required amount of air volume to achieve the specific inflation of the expandable body edge is measured on the syringe, which determines the required volume of monomer to be infused into the expandable body. The air is then evacuated from the expandable body, and the expandable body is filled with the photodynamic light-sensitive liquid monomer. In an embodiment, the expandable body is filled with the determined amount of photodynamic light-sensitive liquid monomer and cured in situ. Once the expandable body has been illuminated and cured, the cured and hardened device is then reinserted and placed within the gap in the bone. In an embodiment, the expandable body is filled with the determined amount of photodynamic light-sensitive liquid monomer and cured on a sterile preparation table or other appropriate sterile site. In an embodiment, placement of the hardened device within the gap in the bone re-aligns the bone. In an embodiment, placement of the hardened device within the gap in the bone stabilizes the bone. In an embodiment, placement of the hardened device within the gap in the bone maintains distraction of the bone. In an embodiment, placement of the hardened device within the gap in the bone restores proper angulation of the bone. The design of the implant allows the implant to accommodate a variety of bone applications. The use of the infusable implant shape allows a surgeon the ability to modify the distraction thickness of the expandable body, the thickness of the expandable body can be adjusted through the infusion of either more or less light-sensitive liquid monomer to achieve the appropriate thickness or distraction of the expandable body, while none of the other dimensions are affected. In an embodiment, a photodynamic device of the present disclosure provides support, stability, angulation and maintains distraction of the identified bone surfaces during the natural healing process of the bone. The expandable body has a shape to substantially fill the interior space of a bone fracture.
A method of maintaining distraction of a fractured distal radius bone includes providing temporary distraction to a fractured distal radius bone to provide a distraction gap; delivering an expandable body in an unexpanded state into the distraction gap; infusing a first fluid into the expandable body to expand the expandable body so that a desired amount of distraction is achieved at the distraction gap; removing the first fluid from the expandable body; determining an amount of first fluid removed from the expandable body; infusing an amount of light-sensitive liquid into the expandable body to expand the expandable body, wherein the amount of light-sensitive liquid is substantially equivalent to the amount of first fluid; curing the light-sensitive liquid in the expandable body to form a rigid photodynamic device; and maintaining a desired amount of distraction at the distraction gap.
A method of maintaining distraction of a fractured distal radius bone includes providing temporary distraction to a fractured distal radius bone to provide a distraction gap; delivering an expandable body in an unexpanded state into the distraction gap; infusing a first fluid into the expandable body to expand the expandable body so that a desired amount of distraction is achieved at the distraction gap; removing the first fluid from the expandable body; removing the expanded expandable body from the distraction gap; determining an amount of first fluid removed from the expandable body; infusing an amount of light-sensitive liquid into the expandable body to expand the expandable body, wherein the amount of light-sensitive liquid is substantially equivalent to the amount of first fluid; curing the light-sensitive liquid in the expandable body to form a rigid photodynamic device; and implanting the photodynamic device into the distraction gap to maintain the desired amount of distraction at the distraction gap.
All patents, patent applications, and published references cited herein are hereby incorporated by reference in their entirety. It will be appreciated that several of the above-disclosed and other features and functions, or alternatives thereof, may be desirably combined into many other different systems or application. Various presently unforeseen or unanticipated alternatives, modifications, variations, or improvements therein may be subsequently made by those skilled in the art.
This application is a continuation of U.S. patent application Ser. No. 12/859,680, filed Aug. 19, 2010, which claims the benefit of and priority to U.S. Provisional Patent Application No. 61/235,231, filed on Aug. 19, 2009, the entirety of these applications are hereby incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
4280233 | Raab | Jul 1981 | A |
4294251 | Greenwald et al. | Oct 1981 | A |
4313434 | Segal | Feb 1982 | A |
4341691 | Anuta | Jul 1982 | A |
4369772 | Miller | Jan 1983 | A |
4414608 | Furihata | Nov 1983 | A |
4422719 | Orcutt | Dec 1983 | A |
4433898 | Nasiri | Feb 1984 | A |
4462394 | Jacobs | Jul 1984 | A |
4466435 | Murray | Aug 1984 | A |
4562598 | Kranz | Jan 1986 | A |
4686973 | Frisch | Aug 1987 | A |
4697584 | Haynes | Oct 1987 | A |
4735625 | Davidson | Apr 1988 | A |
4870953 | DonMicheal et al. | Oct 1989 | A |
4888024 | Powlan | Dec 1989 | A |
4904391 | Freeman | Feb 1990 | A |
4961424 | Kubota et al. | Oct 1990 | A |
4963151 | Ducheyne et al. | Oct 1990 | A |
4969888 | Scholten et al. | Nov 1990 | A |
5030093 | Mitnick | Jul 1991 | A |
5049157 | Mittelmeier et al. | Sep 1991 | A |
5085660 | Lin | Feb 1992 | A |
5092899 | Forte | Mar 1992 | A |
5102413 | Poddar | Apr 1992 | A |
5108404 | Scholten et al. | Apr 1992 | A |
5112333 | Fixel | May 1992 | A |
5207669 | Baker et al. | May 1993 | A |
5295733 | LeBegue | Mar 1994 | A |
5295962 | Crocker et al. | Mar 1994 | A |
5303718 | Krajicek | Apr 1994 | A |
5316550 | Forte | May 1994 | A |
5336699 | Cooke et al. | Aug 1994 | A |
5372598 | Luhr et al. | Dec 1994 | A |
5391144 | Sakurai et al. | Feb 1995 | A |
5415654 | Daikuzono | May 1995 | A |
5423850 | Berger | Jun 1995 | A |
5432876 | Appeldorn et al. | Jul 1995 | A |
5443468 | Johnson | Aug 1995 | A |
5462552 | Kiester | Oct 1995 | A |
5480400 | Berger | Jan 1996 | A |
5538514 | Hawkins | Jul 1996 | A |
5548676 | Savage, Jr. | Aug 1996 | A |
5554111 | Morrey et al. | Sep 1996 | A |
5556429 | Felt | Sep 1996 | A |
5571204 | Nies | Nov 1996 | A |
5658310 | Berger | Aug 1997 | A |
5658963 | Qian et al. | Aug 1997 | A |
5705181 | Cooper et al. | Jan 1998 | A |
5707374 | Schmidt | Jan 1998 | A |
5713901 | Tock | Feb 1998 | A |
5795353 | Felt | Aug 1998 | A |
5824087 | Aspden et al. | Oct 1998 | A |
5827289 | Reiley et al. | Oct 1998 | A |
5888220 | Felt et al. | Mar 1999 | A |
5897557 | Chin et al. | Apr 1999 | A |
5908433 | Eager et al. | Jun 1999 | A |
5972015 | Scribner et al. | Oct 1999 | A |
5980075 | Sheaffer | Nov 1999 | A |
5980253 | Oxman et al. | Nov 1999 | A |
5987199 | Zarian et al. | Nov 1999 | A |
5989230 | Frassica | Nov 1999 | A |
6008264 | Ostler et al. | Dec 1999 | A |
6019761 | Gustilo | Feb 2000 | A |
6019774 | Weiss et al. | Feb 2000 | A |
6033411 | Preissman | Mar 2000 | A |
6039762 | McKay | Mar 2000 | A |
6042380 | De Rowe | Mar 2000 | A |
6048346 | Reiley et al. | Apr 2000 | A |
6059789 | Dinger et al. | May 2000 | A |
6066154 | Reiley et al. | May 2000 | A |
6079868 | Rydell | Jun 2000 | A |
6103203 | Fischer | Aug 2000 | A |
6110176 | Shapira | Aug 2000 | A |
6121341 | Sawhney et al. | Sep 2000 | A |
6127597 | Beyar et al. | Oct 2000 | A |
6140452 | Felt et al. | Oct 2000 | A |
6159236 | Biel | Dec 2000 | A |
6179852 | Strickland et al. | Jan 2001 | B1 |
6195477 | Denuto et al. | Feb 2001 | B1 |
6200134 | Kovac et al. | Mar 2001 | B1 |
6217581 | Tolson | Apr 2001 | B1 |
6223085 | Dann et al. | Apr 2001 | B1 |
6224630 | Bao et al. | May 2001 | B1 |
6235043 | Reiley et al. | May 2001 | B1 |
6241734 | Scribner et al. | Jun 2001 | B1 |
6248110 | Reiley et al. | Jun 2001 | B1 |
6248131 | Felt et al. | Jun 2001 | B1 |
6258089 | Campbell et al. | Jul 2001 | B1 |
6261289 | Levy | Jul 2001 | B1 |
6280456 | Scribner et al. | Aug 2001 | B1 |
6282013 | Ostler et al. | Aug 2001 | B1 |
6290382 | Bourn et al. | Sep 2001 | B1 |
6299597 | Buscemi et al. | Oct 2001 | B1 |
6306177 | Felt et al. | Oct 2001 | B1 |
6319255 | Grundei et al. | Nov 2001 | B1 |
6332894 | Stalcup et al. | Dec 2001 | B1 |
6336914 | Gillespie, III | Jan 2002 | B1 |
6336930 | Stalcup et al. | Jan 2002 | B1 |
6358252 | Shapira | Mar 2002 | B1 |
6387098 | Cole et al. | May 2002 | B1 |
6395007 | Bhatnagar et al. | May 2002 | B1 |
6416531 | Chen | Jul 2002 | B2 |
6416737 | Manolagas et al. | Jul 2002 | B1 |
6419483 | Adam et al. | Jul 2002 | B1 |
6423083 | Reiley et al. | Jul 2002 | B2 |
6425923 | Stalcup et al. | Jul 2002 | B1 |
6440444 | Boyce et al. | Aug 2002 | B2 |
6443988 | Felt et al. | Sep 2002 | B2 |
6447514 | Stalcup et al. | Sep 2002 | B1 |
6458375 | Gertzman et al. | Oct 2002 | B1 |
6478751 | Krueger et al. | Nov 2002 | B1 |
6485512 | Cheng | Nov 2002 | B1 |
6494883 | Ferree | Dec 2002 | B1 |
6524251 | Rabiner et al. | Feb 2003 | B2 |
6524313 | Fassier et al. | Feb 2003 | B1 |
6551321 | Burkinshaw et al. | Apr 2003 | B1 |
6551337 | Rabiner et al. | Apr 2003 | B1 |
6565528 | Mueller | May 2003 | B1 |
6579277 | Rabiner et al. | Jun 2003 | B1 |
6579279 | Rabiner et al. | Jun 2003 | B1 |
6620185 | Harvie et al. | Sep 2003 | B1 |
6623505 | Scribner et al. | Sep 2003 | B2 |
6632235 | Weikel et al. | Oct 2003 | B2 |
6648881 | KenKnight et al. | Nov 2003 | B2 |
6652547 | Rabiner et al. | Nov 2003 | B2 |
6652587 | Felt et al. | Nov 2003 | B2 |
6660013 | Rabiner et al. | Dec 2003 | B2 |
6679873 | Rabiner et al. | Jan 2004 | B2 |
6695781 | Rabiner et al. | Feb 2004 | B2 |
6695782 | Rabiner et al. | Feb 2004 | B2 |
6696073 | Boyce et al. | Feb 2004 | B2 |
6716216 | Boucher et al. | Apr 2004 | B1 |
6719773 | Boucher et al. | Apr 2004 | B1 |
6726691 | Osorio et al. | Apr 2004 | B2 |
6730048 | Hare et al. | May 2004 | B1 |
6733451 | Rabiner et al. | May 2004 | B2 |
6733513 | Boyle et al. | May 2004 | B2 |
6740093 | Hochschuler et al. | May 2004 | B2 |
6755862 | Keynan | Jun 2004 | B2 |
6783530 | Levy | Aug 2004 | B1 |
6802835 | Rabiner et al. | Oct 2004 | B2 |
6818018 | Sawhney | Nov 2004 | B1 |
6852095 | Ray | Feb 2005 | B1 |
6866678 | Shenderova et al. | Mar 2005 | B2 |
6869442 | Cheng | Mar 2005 | B2 |
6875212 | Shaolian et al. | Apr 2005 | B2 |
6885246 | Tsutsui et al. | Apr 2005 | B2 |
6887246 | Bhatnagar et al. | May 2005 | B2 |
6887275 | Carchidi et al. | May 2005 | B2 |
6899713 | Shaolian et al. | May 2005 | B2 |
6899719 | Reiley et al. | May 2005 | B2 |
6932843 | Smith et al. | Aug 2005 | B2 |
6964667 | Shaolian et al. | Nov 2005 | B2 |
6979341 | Scribner et al. | Dec 2005 | B2 |
6981981 | Reiley et al. | Jan 2006 | B2 |
7001431 | Bao et al. | Feb 2006 | B2 |
7008433 | Voellmicke et al. | Mar 2006 | B2 |
7048731 | Altshuler et al. | May 2006 | B2 |
7052498 | Levy et al. | May 2006 | B2 |
7077865 | Bao et al. | Jul 2006 | B2 |
7124067 | Ascenzi | Oct 2006 | B2 |
7141061 | Williams et al. | Nov 2006 | B2 |
7144414 | Harvie et al. | Dec 2006 | B2 |
7153305 | Johnson et al. | Dec 2006 | B2 |
7156861 | Scribner et al. | Jan 2007 | B2 |
7156880 | Evans et al. | Jan 2007 | B2 |
7169140 | Kume | Jan 2007 | B1 |
7215863 | Arenella et al. | May 2007 | B1 |
7241303 | Reiss et al. | Jul 2007 | B2 |
7258692 | Thelen et al. | Aug 2007 | B2 |
7261720 | Stevens et al. | Aug 2007 | B2 |
7320709 | Felt et al. | Jan 2008 | B2 |
7341601 | Eisermann et al. | Mar 2008 | B2 |
7360542 | Nelson et al. | Apr 2008 | B2 |
7407616 | Melikechi et al. | Aug 2008 | B2 |
7419450 | Ito | Sep 2008 | B2 |
7427295 | Ellman et al. | Sep 2008 | B2 |
7547319 | Segal et al. | Jun 2009 | B2 |
7628800 | Sherman et al. | Dec 2009 | B2 |
7632277 | Woll et al. | Dec 2009 | B2 |
7632291 | Stephens et al. | Dec 2009 | B2 |
7666205 | Weikel et al. | Feb 2010 | B2 |
7722620 | Truckai et al. | May 2010 | B2 |
7740656 | Mensah et al. | Jun 2010 | B2 |
7744555 | DiMauro et al. | Jun 2010 | B2 |
7766965 | Bao et al. | Aug 2010 | B2 |
7771476 | Justis et al. | Aug 2010 | B2 |
7776075 | Bruneau et al. | Aug 2010 | B2 |
7806900 | Rabiner | Oct 2010 | B2 |
7811284 | Rabiner | Oct 2010 | B2 |
7811286 | Medoff | Oct 2010 | B2 |
7811290 | Rabiner | Oct 2010 | B2 |
7842040 | Rabiner et al. | Nov 2010 | B2 |
7850711 | Stone et al. | Dec 2010 | B1 |
7857748 | Williams et al. | Dec 2010 | B2 |
7879041 | Rabiner et al. | Feb 2011 | B2 |
7912539 | Doty et al. | Mar 2011 | B2 |
7947015 | Herweck et al. | May 2011 | B2 |
8034071 | Scribner et al. | Oct 2011 | B2 |
8123807 | Kim | Feb 2012 | B2 |
8210729 | O'Leary et al. | Jul 2012 | B2 |
8246628 | Rabiner | Aug 2012 | B2 |
8328402 | O'Leary et al. | Dec 2012 | B2 |
8348956 | Rabiner | Jan 2013 | B2 |
8366711 | Rabiner et al. | Feb 2013 | B2 |
8403968 | Rabiner et al. | Mar 2013 | B2 |
8413664 | Appling | Apr 2013 | B2 |
8512338 | Rabiner et al. | Aug 2013 | B2 |
8574233 | Rabiner et al. | Nov 2013 | B2 |
8668701 | Rabiner et al. | Mar 2014 | B2 |
8672982 | Rabiner et al. | Mar 2014 | B2 |
8684965 | Rabiner et al. | Apr 2014 | B2 |
8708955 | Tilson et al. | Apr 2014 | B2 |
8734460 | Rabiner et al. | May 2014 | B2 |
20010011174 | Reiley et al. | Aug 2001 | A1 |
20010044626 | Reiley et al. | Nov 2001 | A1 |
20020082600 | Shaolian et al. | Jun 2002 | A1 |
20020156482 | Scribner et al. | Oct 2002 | A1 |
20020161373 | Osorio et al. | Oct 2002 | A1 |
20020198526 | Shaolian et al. | Dec 2002 | A1 |
20030028210 | Boyle et al. | Feb 2003 | A1 |
20030083642 | Boyd et al. | May 2003 | A1 |
20030105469 | Karmon | Jun 2003 | A1 |
20030114914 | Cheng | Jun 2003 | A1 |
20030156431 | Gozum et al. | Aug 2003 | A1 |
20030199850 | Chavez et al. | Oct 2003 | A1 |
20030212426 | Olson et al. | Nov 2003 | A1 |
20030229372 | Reiley et al. | Dec 2003 | A1 |
20040006341 | Shaolian et al. | Jan 2004 | A1 |
20040024388 | Altshuler | Feb 2004 | A1 |
20040034434 | Evans et al. | Feb 2004 | A1 |
20040059333 | Carl et al. | Mar 2004 | A1 |
20040059417 | Smith et al. | Mar 2004 | A1 |
20040092948 | Stevens et al. | May 2004 | A1 |
20040098015 | Weikel et al. | May 2004 | A1 |
20040117025 | Reindel | Jun 2004 | A1 |
20040133280 | Trieu | Jul 2004 | A1 |
20040167561 | Boucher et al. | Aug 2004 | A1 |
20040167625 | Beyar et al. | Aug 2004 | A1 |
20040225296 | Reiss et al. | Nov 2004 | A1 |
20040228142 | Takada et al. | Nov 2004 | A1 |
20040230309 | Di Mauro et al. | Nov 2004 | A1 |
20040247641 | Felt et al. | Dec 2004 | A1 |
20050010231 | Myers | Jan 2005 | A1 |
20050015140 | deBeer | Jan 2005 | A1 |
20050015148 | Jansen et al. | Jan 2005 | A1 |
20050043733 | Eisermann et al. | Feb 2005 | A1 |
20050043808 | Felt et al. | Feb 2005 | A1 |
20050049691 | Mericle et al. | Mar 2005 | A1 |
20050090901 | Studer | Apr 2005 | A1 |
20050119662 | Reiley et al. | Jun 2005 | A1 |
20050142315 | DeSimone et al. | Jun 2005 | A1 |
20050149022 | Shaolian et al. | Jul 2005 | A1 |
20050159749 | Levy et al. | Jul 2005 | A1 |
20050171604 | Michalow | Aug 2005 | A1 |
20050192671 | Bao et al. | Sep 2005 | A1 |
20050197711 | Cachia | Sep 2005 | A1 |
20050228260 | Burwell et al. | Oct 2005 | A1 |
20050234453 | Shaolian et al. | Oct 2005 | A1 |
20050251140 | Shaolian et al. | Nov 2005 | A1 |
20050284485 | Nelson et al. | Dec 2005 | A9 |
20060009550 | Messersmith et al. | Jan 2006 | A1 |
20060015105 | Warren et al. | Jan 2006 | A1 |
20060036253 | Leroux et al. | Feb 2006 | A1 |
20060084985 | Kim et al. | Apr 2006 | A1 |
20060100547 | Rabiner et al. | May 2006 | A1 |
20060100635 | Reiley et al. | May 2006 | A1 |
20060100706 | Shadduck et al. | May 2006 | A1 |
20060111726 | Felt et al. | May 2006 | A1 |
20060122625 | Truckai et al. | Jun 2006 | A1 |
20060142747 | Appling | Jun 2006 | A1 |
20060155296 | Richter | Jul 2006 | A1 |
20060173464 | Ellman et al. | Aug 2006 | A1 |
20060183811 | Melikechi et al. | Aug 2006 | A1 |
20060184246 | Zwirkoski | Aug 2006 | A1 |
20060195165 | Gertner et al. | Aug 2006 | A1 |
20060217747 | Ferree | Sep 2006 | A1 |
20060229617 | Meller et al. | Oct 2006 | A1 |
20060247787 | Rydell et al. | Nov 2006 | A1 |
20060253102 | Nance et al. | Nov 2006 | A1 |
20060253200 | Bao et al. | Nov 2006 | A1 |
20060258981 | Eidenschink | Nov 2006 | A1 |
20060264950 | Nelson et al. | Nov 2006 | A1 |
20060264951 | Nelson et al. | Nov 2006 | A1 |
20060264952 | Nelson et al. | Nov 2006 | A1 |
20060265077 | Zwirkoski | Nov 2006 | A1 |
20060271061 | Beyar et al. | Nov 2006 | A1 |
20060276793 | Berry | Dec 2006 | A1 |
20060276819 | Osorio et al. | Dec 2006 | A1 |
20060282169 | Felt et al. | Dec 2006 | A1 |
20060287730 | Segal et al. | Dec 2006 | A1 |
20070027547 | Rydell et al. | Feb 2007 | A1 |
20070067032 | Felt et al. | Mar 2007 | A1 |
20070087031 | Ashman et al. | Apr 2007 | A1 |
20070118143 | Ralph et al. | May 2007 | A1 |
20070123876 | Czartoski et al. | May 2007 | A1 |
20070123877 | Goldin et al. | May 2007 | A1 |
20070123878 | Shaver et al. | May 2007 | A1 |
20070161991 | Altarac et al. | Jul 2007 | A1 |
20070198023 | Sand et al. | Aug 2007 | A1 |
20070225705 | Osorio et al. | Sep 2007 | A1 |
20070233146 | Henniges et al. | Oct 2007 | A1 |
20070255287 | Rabiner | Nov 2007 | A1 |
20080015500 | Herweck et al. | Jan 2008 | A1 |
20080021474 | Bonutti et al. | Jan 2008 | A1 |
20080039854 | Rabiner | Feb 2008 | A1 |
20080080205 | Forrester et al. | Apr 2008 | A1 |
20080103505 | Fransen | May 2008 | A1 |
20080125784 | Rabiner et al. | May 2008 | A1 |
20080154368 | Justis | Jun 2008 | A1 |
20080154373 | Protopsaltis et al. | Jun 2008 | A1 |
20080183122 | Fisher et al. | Jul 2008 | A1 |
20080188858 | Luzzi et al. | Aug 2008 | A1 |
20080234820 | Felt et al. | Sep 2008 | A1 |
20080249529 | Zarda et al. | Oct 2008 | A1 |
20080255560 | Myers et al. | Oct 2008 | A1 |
20080269750 | Justin | Oct 2008 | A1 |
20080287951 | Stoneburger et al. | Nov 2008 | A1 |
20090018524 | Greenhalgh et al. | Jan 2009 | A1 |
20090024166 | Carl et al. | Jan 2009 | A1 |
20090048629 | Rabiner | Feb 2009 | A1 |
20090054900 | Rabiner et al. | Feb 2009 | A1 |
20090093887 | Walter et al. | Apr 2009 | A1 |
20090112196 | Rabiner et al. | Apr 2009 | A1 |
20090118833 | Hudgins et al. | May 2009 | A1 |
20090171265 | Doty et al. | Jul 2009 | A1 |
20090171358 | Chang et al. | Jul 2009 | A1 |
20090177204 | Colleran et al. | Jul 2009 | A1 |
20090182336 | Brenzel et al. | Jul 2009 | A1 |
20090187192 | Rabiner et al. | Jul 2009 | A1 |
20090216232 | Buford, III et al. | Aug 2009 | A1 |
20090228007 | Justin et al. | Sep 2009 | A1 |
20090254064 | Boatman | Oct 2009 | A1 |
20090287309 | Walch et al. | Nov 2009 | A1 |
20090306589 | Tilson et al. | Dec 2009 | A1 |
20100234958 | Linares | Sep 2010 | A1 |
20100241178 | Tilson et al. | Sep 2010 | A1 |
20100249942 | Goswami et al. | Sep 2010 | A1 |
20100256641 | Rabiner et al. | Oct 2010 | A1 |
20100262069 | Rabiner et al. | Oct 2010 | A1 |
20100262188 | Rabiner et al. | Oct 2010 | A1 |
20100265733 | O'Leary et al. | Oct 2010 | A1 |
20100318087 | Scribner et al. | Dec 2010 | A1 |
20100331850 | Rabiner | Dec 2010 | A1 |
20110004213 | Rabiner et al. | Jan 2011 | A1 |
20110009871 | Rabiner | Jan 2011 | A1 |
20110029093 | Bojarski et al. | Feb 2011 | A1 |
20110046746 | Rabiner et al. | Feb 2011 | A1 |
20110082504 | Singhatt et al. | Apr 2011 | A1 |
20110098713 | Rabiner et al. | Apr 2011 | A1 |
20110110114 | Papac et al. | May 2011 | A1 |
20110118740 | Rabiner et al. | May 2011 | A1 |
20110160870 | Baumgartner et al. | Jun 2011 | A1 |
20110166306 | Stansbury et al. | Jul 2011 | A1 |
20110313356 | Rabiner et al. | Dec 2011 | A1 |
20120029102 | Rose et al. | Feb 2012 | A1 |
20120041557 | Frigg | Feb 2012 | A1 |
20120165941 | Rabiner et al. | Jun 2012 | A1 |
20120259375 | Druma et al. | Oct 2012 | A1 |
20120262939 | O'Leary et al. | Oct 2012 | A1 |
20120289968 | Rabiner | Nov 2012 | A1 |
20120316652 | Renganath et al. | Dec 2012 | A1 |
20130003406 | O'Leary et al. | Jan 2013 | A1 |
20130006304 | Rabiner et al. | Jan 2013 | A1 |
20130012998 | Altarac et al. | Jan 2013 | A1 |
20130013009 | Colleran et al. | Jan 2013 | A1 |
20130013010 | Rabiner et al. | Jan 2013 | A1 |
20130023876 | Rabiner et al. | Jan 2013 | A1 |
20130023877 | Rabiner et al. | Jan 2013 | A1 |
20130023886 | Rabiner et al. | Jan 2013 | A1 |
20130041472 | Rabiner et al. | Feb 2013 | A1 |
20130046390 | Rabiner et al. | Feb 2013 | A1 |
20130066326 | Rabiner et al. | Mar 2013 | A1 |
20130158607 | Rabiner et al. | Jun 2013 | A1 |
20130184715 | Rabiner et al. | Jul 2013 | A1 |
20140018806 | DiPoto et al. | Jan 2014 | A1 |
20140135847 | Rabiner et al. | May 2014 | A1 |
20140142581 | Rabiner et al. | May 2014 | A1 |
20140148813 | Rabiner et al. | May 2014 | A1 |
20140163453 | Rabiner et al. | Jun 2014 | A1 |
20140180288 | Rabiner et al. | Jun 2014 | A1 |
Number | Date | Country |
---|---|---|
40 28 466 | Mar 1992 | DE |
0 709 698 | May 1996 | EP |
2001-527437 | Dec 2001 | JP |
2004-526525 | Sep 2002 | JP |
2005-511143 | Apr 2005 | JP |
2006-212425 | Aug 2006 | JP |
9001858 | Mar 1992 | NL |
WO 9838918 | Sep 1998 | WO |
WO 0243628 | Jun 2002 | WO |
WO 03047472 | Jun 2003 | WO |
WO 2004045393 | Jun 2004 | WO |
WO 2004058045 | Jul 2004 | WO |
WO 2004073563 | Sep 2004 | WO |
WO 2004112661 | Dec 2004 | WO |
WO 2005112804 | Dec 2005 | WO |
WO 2006016807 | Feb 2006 | WO |
WO 2008039811 | Apr 2007 | WO |
WO 2007059259 | May 2007 | WO |
WO 2007075375 | Jul 2007 | WO |
WO 2007127255 | Nov 2007 | WO |
WO 2007127260 | Nov 2007 | WO |
WO 2008063265 | May 2008 | WO |
WO 2009059090 | May 2009 | WO |
WO 2009064847 | May 2009 | WO |
WO 2009082688 | Jul 2009 | WO |
WO 2009131999 | Oct 2009 | WO |
WO 2010050965 | May 2010 | WO |
WO 2010118158 | Oct 2010 | WO |
WO 2011060062 | May 2011 | WO |
WO 2011071567 | Jun 2011 | WO |
WO 2011162910 | Dec 2011 | WO |
WO 2012088432 | Jun 2012 | WO |
WO 2013013069 | Jan 2013 | WO |
WO 2013013071 | Jan 2013 | WO |
WO 2013013072 | Jan 2013 | WO |
WO2013059609 | Apr 2013 | WO |
Entry |
---|
USPTO Office Action in U.S. Appl. No. 13/772,947 mailed Jun. 19, 2013. |
USPTO Office Action in U.S. Appl. No. 12/859,680 mailed Jul. 9, 2013. |
USPTO Office Action in U.S. Appl. No. 13/561,249 mailed Sep. 16, 2013. |
USPTO Office Action in U.S. Appl. No. 13/088,916 mailed Sep. 17, 2013. |
USPTO Office Action in U.S. Appl. No. 12/943,544 mailed Sep. 25, 2013. |
USPTO Office Action in U.S. Appl. No. 13/617,557 mailed Oct. 9, 2013. |
Jovanovic et al., “Fixion Nails for Humeral Fractures, Injury”, Int. J. Care Injured, vol. 35, Issue 11, pp. 1140-1142, Nov. 2004. |
Maruyama et al., “Metacarpal Fracture Fixation with Absorbable Polyglycolide Rods and Stainless Steel K Wires: A Biomechanical Comparison”, Journal of Biomedical Materials Research (Applied Biomaterials), vol. 33, Issue 1, pp. 9-12, Apr. 1996. |
Waris et al., “Bioabsorbable Miniplating Versus Metallic Fixation for Metacarpal Fractures”, Clinical Orthopaedics and Related Research, No. 410, pp. 310-319, May 2003. |
Waris et al., “Self-Reinforced Bioabsorbable Versus Metallic Fixation Systems for Metacarpal and Phalangeal Fractures: A Biomechanical Study”, The Journal of Hand Surgery, vol. 27A, No. 5, pp. 902-909, Sep. 2002. |
PCT International Search Report based on PCT/US07/20402 dated Apr. 1, 2008. |
PCT International Search Report based on PCT/US07/10050 dated Apr. 17, 2008. |
PCT International Search Report based on PCT/US07/10038 dated Aug. 27, 2008. |
PCT International Search Report based on PCT/US08/81929 dated Jan. 12, 2009. |
PCT International Search Report based on PCT/US08/81924 dated Feb. 9, 2009. |
PCT International Search Report based on PCT/US08/87630 dated Feb. 24, 2009. |
PCT International Search Report based on PCT/US10/30275 dated Aug. 11, 2010. |
PCT International Search Report based on PCT/US10/56219 dated Jan. 20, 2011. |
PCT International Search Report based on PCT/US10/46003 dated May 24, 2011. |
PCT International Search Report based on PCT/US11/38389 dated Sep. 22, 2011. |
PCT International Search Report based on PCT/US11/66871 dated May 1, 2012. |
USPTO Office Action in U.S. Appl. No. 11/789,906 mailed Apr. 29, 2009. |
USPTO Office Action in U.S. Appl. No. 11/789,906 mailed Mar. 11, 2010. |
USPTO Office Action in U.S. Appl. No. 11/789,906 mailed Apr. 30, 2010. |
USPTO Office Action in U.S. Appl. No. 11/789,907 mailed May 11, 2010. |
USPTO Office Action in U.S. Appl. No. 11/903,123 mailed Jul. 1, 2010. |
USPTO Office Action in U.S. Appl. No. 11/964,370 mailed Dec. 9, 2010. |
USPTO Office Action in U.S. Appl. No. 11/964,370 mailed Apr. 28, 2011. |
USPTO Office Action in U.S. Appl. No. 11/964,370 mailed Sep. 23, 2011. |
USPTO Office Action in U.S. Appl. No. 11/964,370 mailed Mar. 16, 2012. |
USPTO Office Action in U.S. Appl. No. 12/262,411 mailed Sep. 1, 2010. |
USPTO Office Action in U.S. Appl. No. 12/755,784 mailed Dec. 23, 2011. |
USPTO Office Action in U.S. Appl. No. 12/756,014 mailed May 11, 2012. |
USPTO Office Action in U.S. Appl. No. 12/858,924 mailed Oct. 24, 2011. |
USPTO Office Action in U.S. Appl. No. 12/858,924 mailed Apr. 4, 2012. |
USPTO Office Action in U.S. Appl. No. 12/875,460 mailed Mar. 8, 2012. |
USPTO Office Action in U.S. Appl. No. 12/886,288 mailed Dec. 27, 2011. |
USPTO Office Action in U.S. Appl. No. 12/262,370 mailed May 29, 2012. |
USPTO Office Action in U.S. Appl. No. 12/943,544 mailed Jun. 8, 2012. |
USPTO Office Action in U.S. Appl. No. 12/886,288 mailed Jun. 26, 2012. |
USPTO Office Action in U.S. Appl. No. 11/964,370 mailed Jul. 6, 2012. |
Extended European Search Report based on EP 07 75 6022 dated Jul. 30, 2012. |
Extended European Search Report based on EP 07 75 6016 dated Jul. 30, 2012. |
USPTO Office Action in U.S. Appl. No. 12/755,784 mailed Aug. 1, 2012. |
USPTO Office Action in U.S. Appl. No. 12/858,924 mailed Aug. 2, 2012. |
USPTO Office Action in U.S. Appl. No. 12/886,288 mailed Aug. 15, 2012. |
PCT International Search Report based on PCT/US12/47447 dated Oct. 2, 2012. |
PCT International Search Report based on PCT/US12/47446 dated Oct. 15, 2012. |
PCT International Search Report based on PCT/US12/47444 dated Oct. 18, 2012. |
USPTO Office Action in U.S. Appl. No. 12/756,014 mailed Oct. 25, 2012. |
Supplemental European Search Report based on EP 08 87 7881 dated May 15, 2013. |
USPTO Office Action in U.S. Appl. No. 13/617,557 mailed Feb. 4, 2013. |
USPTO Office Action in U.S. Appl. No. 12/755,784 mailed Mar. 13, 2013. |
USPTO Office Action in U.S. Appl. No. 13/616,416 mailed Mar. 25, 2013. |
USPTO Office Action in U.S. Appl. No. 13/561,249 mailed Apr. 23, 2013. |
USPTO Office Action in U.S. Appl. No. 12/262,370 mailed Apr. 26, 2013. |
USPTO Office Action in U.S. Appl. No. 13/088,916 mailed May 13, 2013. |
USPTO Office Action in U.S. Appl. No. 12/859,680 mailed Nov. 9, 2012. |
USPTO Office Action in U.S. Appl. No. 12/943,544 mailed Dec. 3, 2012. |
USPTO Office Action in U.S. Appl. No. 12/859,680 mailed Jan. 17, 2013. |
USPTO Office Action in U.S. Appl. No. 12/262,370 mailed Dec. 14, 2012. |
International Search Report and Written Opinion for PCT/US2012/061047 mailed Jan. 7, 2013. |
USPTO Office Action in U.S. Appl. No. 12/756,014 mailed Jan. 22, 2013. |
USPTO Office Action in U.S. Appl. No. 13/088,916 mailed Jan. 23, 2013. |
Extended European Search Report based on EP 10 76 2390 dated Oct. 30, 2013. |
USPTO Office Action in U.S. Appl. No. 12/262,370 mailed Nov. 21, 2013. |
USPTO Office Action in U.S. Appl. No. 12/983,496 mailed Feb. 5, 2014. |
USPTO Office Action in U.S. Appl. No. 12/756,014 mailed Feb. 13, 2014. |
PCT International Search Report based on PCT/US13/076598 dated Mar. 19, 2014. |
USPTO Office Action in U.S. Appl. No. 13/655,808 mailed Mar. 27, 2014. |
USPTO Office Action in U.S. Appl. No. 13/553,247 mailed May 7, 2014. |
Extended European Search Report based on EP 14156473 dated May 13, 2014. |
USPTO Office Action in U.S. Appl. No. 13/800,518 mailed Jun. 10, 2014. |
USPTO Office Action in U.S. Appl. No. 12/262,370 mailed Jun. 26, 2014. |
USPTO Office Action in U.S. Appl. No. 13/617,557 mailed Jun. 27, 2014. |
Number | Date | Country | |
---|---|---|---|
20130013008 A1 | Jan 2013 | US |
Number | Date | Country | |
---|---|---|---|
61235231 | Aug 2009 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12859680 | Aug 2010 | US |
Child | 13617181 | US |